Inactive Instrument

HEAH SCIE

Equities

HSAQ

KYG4411D1097

Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the First Quarter Ended March 31, 2022

May 13, 2022 at 04:02 pm EDT

Health Sciences Acquisitions Corporation 2 reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.437689 million compared to USD 0.108002 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.

Latest news about HEAH SCIE

Insider Buy: Health Sciences Acquisitions Corp 2	23-01-26	MT
Health Sciences Acquisitions Corporation 2(NasdaqCM:HSAQ) dropped from NASDAQ Composite Index	23-01-26	CI
Orchestra BioMed, Inc. completed the acquisition of Health Sciences Acquisitions Corporation 2 from HSAC 2 Holdings, LLC, RTW Investments, LP and others in a reverse merger transaction.	23-01-25	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-25	CI
Health Sciences Acquisitions Corporation 2 Auditor Raises 'Going Concern' Doubt	23-01-24	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Insider Buy: Health Sciences Acquisitions Corp 2	22-07-25	MT
Orchestra BioMed, Health Sciences Acquisitions Corp. to Merge; Combined Company to be Listed on Nasdaq	22-07-05	MT
Orchestra BioMed, Inc. entered into an agreement and plan of merger agreement to acquire Health Sciences Acquisitions Corporation 2 from HSAC 2 Holdings, LLC, RTW Investments, LP and others for $93 million.	22-07-04	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Health Sciences Acquisitions Corporation 2 Auditor Raises 'Going Concern' Doubt	22-03-30	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Health Sciences Acquisitions Corporation 2 announced that it has received $6 million in funding from HSAC 2 Holdings, LLC	20-08-05	CI
Health Sciences Acquisitions Corporation 2 has completed an IPO in the amount of $139.13044 million.	20-08-04	CI
Health Sciences Acquisitions Corporation 2 announced that it expects to receive $6 million in funding from Hsac 2 Holdings, Llc	20-08-02	CI
Health Sciences Acquisitions Corporation 2 has filed an IPO in the amount of $125 million.	20-07-17	CI

Chart HEAH SCIE

Duration

Period

More charts

Company Profile

Health Sciences Acquisitions Corporation 2 is a blank check company. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It intends to target companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. It has generated no revenues.

Sector

More about the company